PlumX Metrics
Embed PlumX Metrics

METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N-methyladenosine-dependent primary MicroRNA processing

Hepatology, ISSN: 1527-3350, Vol: 65, Issue: 2, Page: 529-543
2017
  • 686
    Citations
  • 0
    Usage
  • 190
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

m6A target microRNAs in serum for cancer detection

Abstract Recent studies have revealed the significant dysregulation of m6A level in peripheral blood in several cancer types and its value in diagnosis. Nonetheless, a

Article Description

N-Methyladenosine (mA) modification has been implicated in many biological processes. However, its role in cancer has not been well studied. Here, we demonstrate that mA modifications are decreased in hepatocellular carcinoma, especially in metastatic hepatocellular carcinoma, and that methyltransferase-like 14 (METTL14) is the main factor involved in aberrant mA modification. Moreover, METTL14 down-regulation acts as an adverse prognosis factor for recurrence-free survival of hepatocellular carcinoma and is significantly associated with tumor metastasis in vitro and in vivo. We confirm that METTL14 interacts with the microprocessor protein DGCR8 and positively modulates the primary microRNA 126 process in an mA-dependent manner. Further experiments show that microRNA 126 inhibits the repressing effect of METTL14 in tumor metastasis. Conclusion: These studies reveal an important role of METTL14 in tumor metastasis and provide a fresh view on mA modification in tumor progression. (Hepatology 2017;65:529-543).

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know